(Q45385615)

English

Motavizumab, a second-generation humanized mAb for the prevention of respiratory syncytial virus infection in high-risk populations.

scientific article published in April 2009

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19330726

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19330726%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 January 2020

title

Motavizumab, a second-generation humanized mAb for the prevention of respiratory syncytial virus infection in high-risk populations (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19330726

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19330726%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 January 2020

author name string

Leonard E Weisman

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19330726

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19330726%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 January 2020

publication date

1 April 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19330726

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19330726%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 January 2020

published in

Current Opinion in Molecular Therapeutics

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19330726

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19330726%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 January 2020

volume

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19330726

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19330726%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 January 2020

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19330726

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19330726%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 January 2020

page(s)

208-218

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19330726

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19330726%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 January 2020

Identifiers

PubMed publication ID

19330726

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19330726

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19330726%20AND%20SRC:MED&resulttype=core&format=json

(Q45385615)

Motavizumab, a second-generation humanized mAb for the prevention of respiratory syncytial virus infection in high-risk populations.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)